Logo image of PSH.AS

Pershing Square Holdings Ltd (PSH.AS) Stock Price, Quote, News and Overview

AMS:PSH - Euronext Amsterdam - GG00BPFJTF46 - Currency: USD

52.7  +1.1 (+2.13%)

Fundamental Rating

3

PSH gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 0 industry peers in the Unkown industry. While PSH seems to be doing ok healthwise, there are quite some concerns on its profitability. PSH is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

PSH had positive earnings in the past year.
PSH had a positive operating cash flow in the past year.
Of the past 5 years PSH 4 years were profitable.
PSH had a positive operating cash flow in 4 of the past 5 years.
PSH.AS Yearly Net Income VS EBIT VS OCF VS FCFPSH.AS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 1B -1B 2B 3B

1.2 Ratios

Industry RankSector Rank
ROA 14.23%
ROE 17.34%
ROIC 10.72%
ROA(3y)7.6%
ROA(5y)16.07%
ROE(3y)10.03%
ROE(5y)21.45%
ROIC(3y)N/A
ROIC(5y)N/A
PSH.AS Yearly ROA, ROE, ROICPSH.AS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20 -20

1.3 Margins

PSH's Profit Margin has been stable in the last couple of years.
In the last couple of years the Operating Margin of PSH has remained more or less at the same level.
In the last couple of years the Gross Margin of PSH has remained more or less at the same level.
Industry RankSector Rank
OM 75.58%
PM (TTM) 75.97%
GM 75.67%
OM growth 3Y0.34%
OM growth 5YN/A
PM growth 3Y0.97%
PM growth 5YN/A
GM growth 3Y0.36%
GM growth 5YN/A
PSH.AS Yearly Profit, Operating, Gross MarginsPSH.AS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -500 -1K -1.5K

More info and screens

6

2. Health

2.1 Basic Checks

The number of shares outstanding for PSH has been reduced compared to 1 year ago.
PSH has less shares outstanding than it did 5 years ago.
PSH has a better debt/assets ratio than last year.
PSH.AS Yearly Shares OutstandingPSH.AS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 1B 2B 3B 4B 5B
PSH.AS Yearly Total Debt VS Total AssetsPSH.AS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 5B 10B 15B

2.2 Solvency

An Altman-Z score of 4.05 indicates that PSH is not in any danger for bankruptcy at the moment.
The Debt to FCF ratio of PSH is 1.36, which is an excellent value as it means it would take PSH, only 1.36 years of fcf income to pay off all of its debts.
PSH has a Debt/Equity ratio of 0.19. This is a healthy value indicating a solid balance between debt and equity.
Even though the debt/equity ratio score it not favorable for PSH, it has very limited outstanding debt, so we won't put too much weight on the DE evaluation.
Industry RankSector Rank
Debt/Equity 0.19
Debt/FCF 1.36
Altman-Z 4.05
ROIC/WACCN/A
WACCN/A
PSH.AS Yearly LT Debt VS Equity VS FCFPSH.AS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 2B 4B 6B 8B 10B

2.3 Liquidity

A Current Ratio of 16.44 indicates that PSH has no problem at all paying its short term obligations.
A Quick Ratio of 16.44 indicates that PSH has no problem at all paying its short term obligations.
Industry RankSector Rank
Current Ratio 16.44
Quick Ratio 16.44
PSH.AS Yearly Current Assets VS Current LiabilitesPSH.AS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 500M 1B 1.5B 2B 2.5B

More info and screens

2

3. Growth

3.1 Past

The earnings per share for PSH have decreased strongly by -18.33% in the last year.
Measured over the past years, PSH shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -10.09% on average per year.
Looking at the last year, PSH shows a decrease in Revenue. The Revenue has decreased by -7.19% in the last year.
Measured over the past years, PSH shows a very strong growth in Revenue. The Revenue has been growing by 158.59% on average per year.
EPS 1Y (TTM)-18.33%
EPS 3Y-10.09%
EPS 5YN/A
EPS Q2Q%-29.53%
Revenue 1Y (TTM)-7.19%
Revenue growth 3Y-12.23%
Revenue growth 5Y158.59%
Sales Q2Q%-23.79%

3.2 Future

PSH is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -32.91% yearly.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y-53.59%
EPS Next 2Y-46.26%
EPS Next 3Y-32.91%
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
PSH.AS Yearly Revenue VS EstimatesPSH.AS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 1B -1B 2B 3B 4B
PSH.AS Yearly EPS VS EstimatesPSH.AS Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 0 5 -5 10 15

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 4.67 indicates a rather cheap valuation of PSH.
PSH is valuated cheaply when we compare the Price/Earnings ratio to 28.78, which is the current average of the S&P500 Index.
With a Price/Forward Earnings ratio of 13.78, PSH is valued correctly.
The average S&P500 Price/Forward Earnings ratio is at 21.32. PSH is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 4.67
Fwd PE 13.78
PSH.AS Price Earnings VS Forward Price EarningsPSH.AS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Industry RankSector Rank
P/FCF 6.73
EV/EBITDA N/A
PSH.AS Per share dataPSH.AS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40 50

4.3 Compensation for Growth

A cheap valuation may be justified as PSH's earnings are expected to decrease with -32.91% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-46.26%
EPS Next 3Y-32.91%

More info and screens

2

5. Dividend

5.1 Amount

PSH has a Yearly Dividend Yield of 1.31%. Purely for dividend investing, there may be better candidates out there.
Compared to an average S&P500 Dividend Yield of 2.46, PSH's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 1.31%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years2
Div Non Decr Years5
PSH.AS Yearly Dividends per sharePSH.AS Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6

5.3 Sustainability

PSH pays out 4.70% of its income as dividend. This is a sustainable payout ratio.
DP4.7%
EPS Next 2Y-46.26%
EPS Next 3Y-32.91%
PSH.AS Yearly Income VS Free CF VS DividendPSH.AS Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 1B -1B 2B 3B
PSH.AS Dividend Payout.PSH.AS Dividend Payout, showing the Payout Ratio.PSH.AS Dividend Payout.PayoutRetained Earnings

More info and screens

Pershing Square Holdings Ltd

AMS:PSH (1/30/2025, 7:00:00 PM)

52.7

+1.1 (+2.13%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)11-21 2024-11-21
Earnings (Next)05-27 2025-05-27
Inst Owners5.79%
Inst Owner ChangeN/A
Ins Owners1%
Ins Owner ChangeN/A
Market Cap11.12B
Analysts76.67
Price Target54.47 (3.36%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.31%
Yearly Dividend0.53
Dividend Growth(5Y)N/A
DP4.7%
Div Incr Years2
Div Non Decr Years5
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)4.71%
PT rev (3m)4.71%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)38.39%
EPS NY rev (3m)38.39%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 4.67
Fwd PE 13.78
P/S 4.01
P/FCF 6.73
P/OCF 6.73
P/B 0.92
P/tB 0.92
EV/EBITDA N/A
EPS(TTM)11.28
EY21.4%
EPS(NY)3.83
Fwd EY7.26%
FCF(TTM)7.83
FCFY14.87%
OCF(TTM)7.83
OCFY14.87%
SpS13.13
BVpS57.52
TBVpS57.52
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 14.23%
ROE 17.34%
ROCE 14.3%
ROIC 10.72%
ROICexc 12.21%
ROICexgc 12.21%
OM 75.58%
PM (TTM) 75.97%
GM 75.67%
FCFM 59.67%
ROA(3y)7.6%
ROA(5y)16.07%
ROE(3y)10.03%
ROE(5y)21.45%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y-19.79%
ROICexcg growth 5YN/A
ROICexc growth 3Y-18.7%
ROICexc growth 5YN/A
OM growth 3Y0.34%
OM growth 5YN/A
PM growth 3Y0.97%
PM growth 5YN/A
GM growth 3Y0.36%
GM growth 5YN/A
F-Score5
Asset Turnover0.19
Health
Industry RankSector Rank
Debt/Equity 0.19
Debt/FCF 1.36
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 26.67
Cash Conversion N/A
Profit Quality 78.55%
Current Ratio 16.44
Quick Ratio 16.44
Altman-Z 4.05
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-18.33%
EPS 3Y-10.09%
EPS 5YN/A
EPS Q2Q%-29.53%
EPS Next Y-53.59%
EPS Next 2Y-46.26%
EPS Next 3Y-32.91%
EPS Next 5YN/A
Revenue 1Y (TTM)-7.19%
Revenue growth 3Y-12.23%
Revenue growth 5Y158.59%
Sales Q2Q%-23.79%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-23.6%
EBIT growth 3Y-11.93%
EBIT growth 5YN/A
EBIT Next Year-67.94%
EBIT Next 3Y-32.74%
EBIT Next 5YN/A
FCF growth 1Y335.61%
FCF growth 3Y47.51%
FCF growth 5YN/A
OCF growth 1Y335.61%
OCF growth 3Y47.51%
OCF growth 5YN/A